Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

DUSA PHARMACEUTICALS INC (DUSA) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $35.03 Metrics
OS: 25.0 M 12 % ROE
Market cap: $877 M 87 % ROIC
Net cash: $32.3 M $1.29 per share
EV: $844 M

 
TTM Valuation
EBITDA $7.3 M 115.3 x EV/EBITDA
EBIT $6.8 M 124.7 x EV/EBIT
EPS $0.12 292.3 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04
Revenues45.336.428.330.228.226.412.79.6
            Revenue growth24.4%28.5%-6.2%7.1%6.8%107.6%33.0%886.2%
Cost of goods sold6.96.46.030.28.427.07.65.5
Gross profit38.430.022.30.019.8-0.55.14.1
            Gross margin84.7%82.4%78.8%0.2%70.3%-2.0%40.3%43.0%
Sales and marketing15.413.212.913.113.312.69.17.6
Research and development5.34.94.36.66.06.25.66.5
General and administrative10.09.18.09.210.311.26.77.2
EBIT7.82.7-2.8-6.2-9.2-14.8-16.2-17.2
            EBIT margin17.1%7.5%-10.0%-20.7%-32.5%-56.2%-127.6%-179.9%
Pre-tax income6.82.6-2.90.0-14.7-31.3-15.0-15.6
Income taxes-0.5-0.1-0.20.00.00.00.00.0
            Tax rate  5.6% 0.0%0.0%0.0%0.0%
Net income7.32.7-2.50.0-14.7-31.3-15.0-15.6
            Net margin16.2%7.4%-8.9%0.0%-52.1%-118.7%-117.9%-163.4%
 
Diluted EPS$0.26$0.10($0.11)$0.00($0.73)($1.65)($0.89)($0.96)
Shares outstanding (diluted)26.424.824.124.120.319.016.916.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy